Network TodayNetwork Today
    What's Hot

    Smuggling the abortion pill into Texas could land you in legal peril, if this bill becomes law

    March 20, 2023

    2 Illinois teens die after sledding accident at Colorado ski resort

    March 20, 2023

    Stuart Hodes, Who Danced With Martha Graham, Is Dead at 98

    March 20, 2023
    Facebook Twitter Instagram
    • About
    • Privacy Policy
    • Terms
    • Contact
    Facebook Twitter Instagram
    Monday, March 20
    Network TodayNetwork Today
    • Home
    • News
    • Politics
    • Business
    • Energy
    • Technology
    • Health
    • Lifestyle
    • Sports
    Network TodayNetwork Today
    Home » F.D.A. Panel Rejects Lilly’s Cancer Drug Tested Only in China

    F.D.A. Panel Rejects Lilly’s Cancer Drug Tested Only in China

    February 11, 20222 Mins Read Health
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Email

    The agency has long had strict rules about approving drugs that were tested solely overseas, requiring that the data be applicable to patients and medical practice in the United States, that the investigators had “recognized competence” and that the agency be able to validate the data.

    In a withering critique of Lilly’s submission on this new trial from China, F.D.A. staff members assigned to conduct an analysis said that on every count the sintilimab application fell short. One issue was how to evaluate the drug. The study asked how long it took before the cancer started growing again or before the patient died. That endpoint, known as progression free survival, Dr. Pazdur said at the meeting, is out of date for such studies. Instead, the appropriate endpoint, he suggested, is what matters to patients most — how long will they live.

    “There’s a famous story of Avastin in metastatic breast cancer,” Dr. Berry said. “It showed enormous benefit for progression-free survival, but with additional follow-up it was not beneficial for overall survival.”

    A few years ago, progression-free survival might have been more acceptable but, Dr. Pazdur said, it no longer is and it’s another example of how “the landscape has changed.”To get Lilly’s drug approved, the panel voted to recommend requiring another trial that would be applicable to U.S. patients.

    But Dr. Jorge Nieva, associate professor of medicine at the University of Southern California, who was the only dissenting panel member, said there was no evidence that the data was unreliable and that it was not the panel’s job to determine how many drugs on the market would be too many.

    “Having more drugs competing for those same patients will have, I think, greater impact on equity than the need for diversity in clinical trial enrollment, which I believe is important,” Dr. Nieva said.

    But Dr. Pazdur’s views carried the day, alluding to more policy changes, perhaps.

    “There is a change in our perception of what we want from international trials,” he said. China has, so far, rarely participated.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    Deadly Fungus Spread Rapidly During the Pandemic, C.D.C. Says

    March 20, 2023

    Be well: Spring-clean your medicine cabinet to remove expired drugs

    March 20, 2023

    Caffeine, the wonder drug? Study suggests more coffee could lower body fat and prevent type 2 diabetes

    March 20, 2023

    Lab Leak or Not? How Politics Shaped the Battle Over Covid’s Origin

    March 19, 2023

    COVID-19 pandemic expected to end this year ‘as a public health emergency,’ says World Health Organization

    March 19, 2023

    Military pilots and ground crews showing high rates of cancer, Pentagon study reveals

    March 19, 2023
    Trending

    Smuggling the abortion pill into Texas could land you in legal peril, if this bill becomes law

    March 20, 2023

    2 Illinois teens die after sledding accident at Colorado ski resort

    March 20, 2023

    Stuart Hodes, Who Danced With Martha Graham, Is Dead at 98

    March 20, 2023

    No handcuffs: Ex-prosecutor says Secret Service, NYPD could arrange polite Trump surrender

    March 20, 2023
    Latest News

    2 Oregon police officers fatally shoot man who was having a mental health crisis

    February 9, 2023

    2 Monkeys Taken From Dallas Zoo Are Found at an Empty Home

    February 1, 2023

    Black Equestrians Want to Be Safe. But They Can’t Find Helmets.

    March 3, 2023

    S.E.C. Inquiry Into Former Senator’s Stock Sales Is Closed Without Charges

    January 6, 2023

    Missing California woman Alexis Gabe’s accused killer handwrote directions to area where he left body: Family

    July 13, 2022

    Missing Athena Brownfield: authorities say search for 4-year-old Oklahoma girl is now a ‘recovery operation’

    January 16, 2023

    Network Today is one of the biggest English news portal, we provide the latest news from all around the world.

    We're social. Connect with us:

    Facebook Twitter Instagram Pinterest YouTube
    Recent

    Smuggling the abortion pill into Texas could land you in legal peril, if this bill becomes law

    March 20, 2023

    2 Illinois teens die after sledding accident at Colorado ski resort

    March 20, 2023

    Stuart Hodes, Who Danced With Martha Graham, Is Dead at 98

    March 20, 2023
    Featured

    Daniels Win the Top DGA Award. Will They Take the Oscar, Too?

    February 19, 2023

    Top Democrats, Alleging Cover-Up, Seek Testimony on Secret Service Texts

    August 2, 2022

    EPA director advises East Palestine children to stay out of creeks, streams amid Ohio train derailment fallout

    March 1, 2023
    Copyright ©️ All rights reserved | Network Today
    • About
    • Privacy Policy
    • Terms
    • Contact

    Type above and press Enter to search. Press Esc to cancel.